Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 5Lung Neoplasms 3Uterine Cervical Neoplasms 2Neoplasms 2Prostatic Neoplasms 1Postoperative Complications 1Panic Disorder 1Emotional Regulation 1Colorectal Neoplasms 1Anxiety Disorders 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Relaxation Therapy × Clear all
NCT00735618 2011-12-19

Relaxation and Heart Rate Variability

M.D. Anderson Cancer Center

Phase NA Completed
20 enrolled 3 charts

Anxiety Disorders, Neoplasms, Panic Disorder

NCT00435474 2009-06-09

Malignant Wounds, Wound Treatment, Psycho-Social Support and Relaxation Therapy

Rigshospitalet, Denmark

Phase 3 Completed
70 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡